`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`
`ALLERGAN, INC.,
`
` Plaintiff,
`
`v.
`
`TEVA PHARMACEUTICALS USA, INC., et
`al.,
`
` Defendants.
`
`
` Civil Action No. 2:15-cv-1455 WCB LEAD
`
`
`
`
`
`PLAINTIFF’S PRODUCTION OF DOCUMENTS IN RESPONSE TO COURT’S
`OCTOBER 6, 2017 ORDER
`
`The Court’s October 6, 2017 Order (Dkt. 503) directed Allergan to provide the Court
`
`with “copies of those documents pertinent to the terms of the assignment of the patents-in-suit to
`
`the Tribe, including any information as to payments made or to be made either by the Tribe or by
`
`Allergan in connection with the transaction.” (Dkt. 503 at 2.) In its filing dated October 9, 2017
`
`(Dkt. 505; Dkt. 508), Allergan provided the Court with the assignment and license documents
`
`themselves. (Dkt. 508 at Exhibits A-D). Allergan had previously produced those same materials
`
`to Defendants on September 8, 2017 and provided them again to Defendants yesterday. Allergan
`
`now provides the additional materials requested in the Court’s Order, which are attached hereto
`
`and described below:
`
`• Exhibit E – Patent assignment as recorded with the PTO (Reel 043532, Frame
`
`0422), dated Sept. 8, 2017;
`
`• Exhibit F – Allergan Press Release dated Sept. 8, 2017;
`
`• Exhibit G – Saint Regis Mohawk Tribe Press Release dated Sept. 8, 2017;
`
`• Exhibit H – Saint Regis Mohawk Tribe Press Release dated Sept. 14, 2017;
`
`
`
`Case 2:15-cv-01455-WCB Document 510 Filed 10/10/17 Page 2 of 6 PageID #: 25542
`
`• Exhibit I – Saint Regis Mohawk Tribe Press Release dated Oct. 5, 2017;
`
`• Exhibit J – Letter from Allergan to Senators Grassley and Feinstein, dated Oct. 3,
`
`2017;
`
`• Exhibit K – Redacted Allergan Bank Statement, dated Sept. 29, 2017, showing
`
`wire transfer on Sept. 8, 2017 to the Trust Account of Shore Chan Depumpo LLP,
`
`counsel for the Saint Regis Mohawk Tribe; and
`
`• Exhibit L – Saint Regis Mohawk Tribe’s Motion to Dismiss for Lack of
`
`Jurisdiction Based on Tribal Sovereign Immunity, filed in the pending IPR
`
`proceedings on the patents-in-suit on September 22, 2017.
`
`As provided in the Court’s October 10 Order (Dkt. 509), Allergan is also providing these
`
`additional materials (Exhibits E-L) to Defendants at the same time. With the simultaneous
`
`service of this response, Defendants have all of the same information that has been supplied to
`
`the Court. There are no other agreements, side-agreements, or payments between Allergan and
`
`the Tribe that are not reflected in the September 8, 2017 documents, i.e., those attached as
`
`Exhibits A-D of Allergan’s October 9, 2017 filing with the Court.
`
`In its October 10 Order, the Court also directed Allergan to identify what the “good and
`
`valuable consideration” referred to in the assignment of the patents-in-suit to the Tribe
`
`“consisted of and to provide any documentary evidence confirming the payment by the Tribe of
`
`any such consideration for the assignment of the patents.” (Dkt. 509 at 2-3.) The promises and
`
`commitments made by the Tribe in the simultaneously-executed assignment and license
`
`agreements, and the subsequent performance of those promises, provides such consideration.
`
`See United States v. Dreier, 952 F. Supp. 2d 582, 590 (S.D.N.Y. 2013) (“Black-letter contract
`
`law, in turn, provides that ‘when a man acts in consideration of a conditional promise, if he gets
`
`
`
`2
`
`
`
`Case 2:15-cv-01455-WCB Document 510 Filed 10/10/17 Page 3 of 6 PageID #: 25543
`
`the promise he gets all that he is entitled to by his act, and if, as events turn out, the condition is
`
`not satisfied, and the promise calls for no performance, there is no failure of consideration.’”
`
`(quoting 3 Williston on Contracts § 7:18 (4th ed.)); Kinley Corp. v. Ancira, 859 F. Supp. 652,
`
`657 (W.D.N.Y. 1994) (“A benefit to a promisor or a detriment to a promisee is sufficient
`
`consideration for a contract. … ‘Far from consideration needing to be coextensive or even
`
`proportionate, the value or measurability of the thing forborne or promised is not crucial as long
`
`as it is acceptable to the promisee.’”) (citation omitted); Bank of Bermuda, Ltd. v. Rosenbloom,
`
`76 Civ. 1830 (GLG), 1976 U.S. Dist. LEXIS 11648, at *7-8 (S.D.N.Y. Jan. 1, 1976) (“It is
`
`hornbook law that in the absence of fraud any benefit conferred upon a promisor in exchange for
`
`his promise is sufficient to constitute a valid consideration and the court will not look to the
`
`sufficiency or the insufficiency of such benefit conferred.”); see also Memorylink Corp. v.
`
`Motorola Sols., Inc., Motorola Mobility, Inc., 773 F.3d 1266, 1271 (Fed. Cir. 2014) (“We agree
`
`with Motorola that there is no genuine issue of material fact that consideration existed, because
`
`the Assignment explicitly acknowledges consideration for the sale, assignment, and transfer of
`
`rights relating to the wireless video technology.”).
`
`By the terms of the assignment agreement, the Tribe promised that it “will not waive its
`
`or any other Tribal Party’s sovereign immunity in relation to any inter partes review or any other
`
`proceeding in the United States Patent and Trademark Office or any administrative proceeding
`
`that may be filed for the purpose of invalidating or rendering unenforceable any Assigned
`
`Patents.” (Dkt. 508, Ex. B (Patent Assignment Agreement) at § 12(i).) The Tribe has performed
`
`that promise by asserting its sovereign immunity in the pending IPR proceedings on the patents-
`
`in-suit and by filing its Motion to Dismiss for Lack of Jurisdiction Based on Tribal Sovereign
`
`Immunity on September 22, 2017. (See Ex. L.)
`
`
`
`3
`
`
`
`Case 2:15-cv-01455-WCB Document 510 Filed 10/10/17 Page 4 of 6 PageID #: 25544
`
`In addition, in the License Agreement by which the Tribe granted a limited field of use
`
`exclusive license to Allergan, the Tribe agreed “that it will and shall assert its sovereign
`
`immunity in any Contested PTO Proceeding, including in the IPR Proceedings.” (Dkt. 508, Ex.
`
`C (License) at § 5.3; see also id. at § 7.2.12.) The Tribe also agreed that, with respect to
`
`proceedings in this Court, it “(i) consents to join as a party and (ii) shall not assert its sovereign
`
`immunity.” (Id. at § 5.2.2.) Further, the Tribe agreed to assist and cooperate with all
`
`enforcement proceedings, prosecution, and contested Patent Office proceedings concerning the
`
`patents-in-suit, and is doing so. (Id. at § 5.2.)
`
`When and how the Tribe asserts its sovereign immunity is an issue of critical importance
`
`to the Tribe. The Tribe’s promises, agreements, and actions with respect to asserting its
`
`sovereign immunity in the IPR proceedings, as well as the Tribe’s participation in this
`
`proceeding (where the Tribe agreed that it will not assert its sovereign immunity), serves as good
`
`and valuable consideration under the law, including the law of the State of New York, which
`
`governs the assignment and license agreements. See Dreier, 952 F. Supp. 2d at 590; Kinley, 859
`
`F. Supp. at 657.
`
`Dated: October 10, 2017
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`FISH & RICHARDSON P.C.
`
`
`
`/s/ Susan E. Morrison
`By:
`Jonathan E. Singer (CA Bar No. 187908)
`LEAD ATTORNEY
`singer@fr.com
`Juanita R. Brooks (CA Bar No. 75934)
`brooks@fr.com
`12390 El Camino Real
`San Diego, CA 92130
`Telephone: 858-678-5070
`Facsimile: 858-678-5099
`
`
`4
`
`
`
`Case 2:15-cv-01455-WCB Document 510 Filed 10/10/17 Page 5 of 6 PageID #: 25545
`
`Michael J. Kane (MN Bar No. 0247625)
`kane@fr.com
`Deanna J. Reichel (MN Bar No. 0326513)
`reichel@fr.com
`Joseph A. Herriges (MN Bar No. 390350)
`herriges@fr.com
`60 South Sixth Street, #3200
`Minneapolis, MN 55402
`Telephone: (612) 335-5070
`Facsimile: (612) 288-9696
`
`Douglas E. McCann (DE Bar No. 3852)
`dmccann@fr.com
`Susan Morrison (DE Bar No. 4690)
`morrison@fr.com
`Robert M. Oakes (DE Bar No. 5217)
`oakes@fr.com
`222 Delaware Avenue, 17th Floor
`Wilmington, DE 19801
`Telephone: (302) 652-5070
`Facsimile: (302) 652-0607
`
`J. Wesley Samples (OR Bar No. 121784)
`samples@fr.com
`901 15th Street, N.W., 7th Floor
`Washington, D.C. 20005
`Telephone: (202) 783-5070
`Facsimile: (202) 783-2331
`
`T. John Ward, Jr.
`State Bar No. 00794818
`E-mail: jw@wsfirm.com
`Wesley Hill
`State Bar No. 24032294
`E-mail: wh@wsfirm.com
`Claire Abernathy Henry
`State Bar No. 24053063
`E-mail: claire@wsfirm.com
`Andrea L. Fair
`State Bar No. 24078488
`E-mail: andrea@wsfirm.com
`WARD, SMITH & HILL, PLLC
`1507 Bill Owens Parkway
`Longview, Texas 75604
`Telephone: (903) 757-6400
`Facsimile: (903) 757-2323
`
`5
`
`
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 510 Filed 10/10/17 Page 6 of 6 PageID #: 25546
`
`
`
`
`
`
`
`
`
`
`
`
`
`COUNSEL FOR PLAINTIFF
`ALLERGAN, INC.
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that the foregoing document was filed electronically in
`
`compliance with Local Rule CV-5(a) on October 10, 2017. As such, this document was served on
`
`all counsel who are deemed to have consented to electronic service. Local Rule CV-5(a)(3)(A).
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Susan E. Morrison
`Susan E. Morrison
`
`6
`
`